Helius Medical Technologies is trading 5.45% down at $2.52, in line with broader risk-off pressure on U.S. stock futures.
- Treasury yields and oil rebounded as investors remained cautious ahead of the FOMC minutes.
- Search results did not surface a clear October 7 company-specific catalyst.
- Recent financing news was dated September 30 and does not by itself explain this session’s move.